These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 30262176)

  • 1. Prescribing for people with type 2 diabetes and renal impairment in Australian general practice: A national cross sectional study.
    Manski-Nankervis JE; Thuraisingam S; Sluggett JK; Lau P; Blackberry I; Ilomaki J; Furler J; Bell JS
    Prim Care Diabetes; 2019 Apr; 13(2):113-121. PubMed ID: 30262176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study.
    Manski-Nankervis JA; Thuraisingam S; Sluggett JK; Kilov G; Furler J; O'Neal D; Jenkins A
    BMC Fam Pract; 2019 Feb; 20(1):29. PubMed ID: 30777033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis.
    Hinton W; Feher MD; Munro N; Joy M; de Lusignan S
    Cardiovasc Diabetol; 2021 Jun; 20(1):130. PubMed ID: 34183018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperglycemic Medication Use Among Medicare Beneficiaries With Heart Failure, Diabetes Mellitus, and Chronic Kidney Disease.
    Patel PA; Liang L; Khazanie P; Hammill BG; Fonarow GC; Yancy CW; Bhatt DL; Curtis LH; Hernandez AF
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27413035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.
    Clemens KK; Liu K; Shariff S; Schernthaner G; Tangri N; Garg AX
    Diabetes Obes Metab; 2016 Jun; 18(6):607-14. PubMed ID: 26939711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease in type 2 diabetic patients followed-up by primary care physicians in Switzerland: prevalence and prescription of antidiabetic drugs.
    Lamine F; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2016; 146():w14282. PubMed ID: 26922155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How are patients with type 2 diabetes and renal disease monitored and managed? Insights from the observational OREDIA study.
    Penfornis A; Blicklé JF; Fiquet B; Quéré S; Dejager S
    Vasc Health Risk Manag; 2014; 10():341-52. PubMed ID: 24966684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing use of antidiabetic drugs in the UK: trends in prescribing 2000-2017.
    Wilkinson S; Douglas I; Stirnadel-Farrant H; Fogarty D; Pokrajac A; Smeeth L; Tomlinson L
    BMJ Open; 2018 Jul; 8(7):e022768. PubMed ID: 30056393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence of chronic kidney disease in Finnish patients with type 2 diabetes treated in primary care.
    Metsärinne K; Bröijersen A; Kantola I; Niskanen L; Rissanen A; Appelroth T; Pöntynen N; Poussa T; Koivisto V; Virkamäki A;
    Prim Care Diabetes; 2015 Feb; 9(1):31-8. PubMed ID: 25066820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment choices for the glycaemic management of patients with type 2 diabetes and chronic kidney disease: Analysis of the SAIL patient linked dataset.
    Min T; Davies GI; Rice S; Chess J; Stephens JW
    Diabetes Metab Syndr; 2018; 12(2):123-127. PubMed ID: 29239764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antidiabetics use among diabetic type 2 patients with chronic kidney disease. Do nephrologists take account of recommendations?
    Muller C; Dimitrov Y; Imhoff O; Richter S; Ott J; Krummel T; Bazin-Kara D; Chantrel F; Hannedouche T; ;
    J Diabetes Complications; 2016; 30(4):675-80. PubMed ID: 26900098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment Patterns in Patients With Newly Diagnosed Type 2 Diabetes in China: A Retrospective, Longitudinal Database Study.
    Wang C; Gao Y; Zhu L; Huang M; Wu Y; Xuan J
    Clin Ther; 2019 Aug; 41(8):1440-1452. PubMed ID: 31155146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electronic records suggest suboptimal management of chronic kidney disease in general practice.
    Pilotto LS; Ball PA; Smithard JM; Kennedy DR
    Aust J Rural Health; 2012 Aug; 20(4):195-9. PubMed ID: 22827427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of chronic kidney disease in Australian general practice: National Prescribing Service MedicineWise MedicineInsight dataset.
    Radford J; Kitsos A; Stankovich J; Castelino R; Khanam M; Jose M; Peterson G; Saunder T; Wimmer B; Razizaidi T
    Nephrology (Carlton); 2019 Oct; 24(10):1017-1025. PubMed ID: 30467996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial treatment of diabetes in Italy. A nationwide population-based study from of the ARNO Diabetes Observatory.
    Bonora E; Cataudella S; Marchesini G; Miccoli R; Vaccaro O; Fadini GP; Martini N; Rossi E;
    Nutr Metab Cardiovasc Dis; 2021 Aug; 31(9):2661-2668. PubMed ID: 34218990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antidiabetics' usage in type 2 diabetes mellitus: Are prescribing guidelines adhered to? A single centre study.
    Khalil V; Sajan C; Tsai T; Ma D
    Diabetes Metab Syndr; 2018 Sep; 12(5):635-641. PubMed ID: 29666033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of anti-diabetic medication use in patients with type 2 diabetes mellitus in England and Wales.
    Datta-Nemdharry P; Thomson A; Beynon J; Donegan K
    Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):127-135. PubMed ID: 27642000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study.
    Forbes AK; Hinton W; Feher MD; Elson W; Joy M; Ordóñez-Mena JM; Fan X; Cole NI; Banerjee D; Suckling RJ; de Lusignan S; Swift PA
    EClinicalMedicine; 2024 Feb; 68():102426. PubMed ID: 38304744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adherence to anti-diabetic drug therapy and self management practices among type-2 diabetics in Nigeria.
    Yusuff KB; Obe O; Joseph BY
    Pharm World Sci; 2008 Dec; 30(6):876-83. PubMed ID: 18784982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.